openPR Logo
Press release

Chronic Phase Markers Market Global Industry Analysis and Forecast Till 2027

11-22-2017 07:41 AM CET | Health & Medicine

Press release from: Future Market Insights

/ PR Agency: Future Market Insights
Chronic Phase Markers Market Global Industry Analysis

Markers are broadly categorized as biomarkers or molecular markers and biochemical markers. Biomarker, also known as biological marker is commonly used to carry out detection of living organism which acts as a causative agent for specific diseases. It usually refers to a measurable indicator for various biological states or disease conditions in the human body. Biomarker is any substance that can be utilized as an indicator of specific disease condition and is often evaluated to detect pathogenic processes, normal biological process, or pharmacologic response to medical treatment. The elevated levels or absence of these biological markers may indicate the onset or late stage of a chronic disease. However, chronic phase indicates early stages of chronic leukemia which is a type of cancer in white blood cells. It constitutes high amounts of abnormal white blood cells in bone marrow and blood.

Request For ToC @

Chronic phase markers are the biomarkers that help in detection of a disease condition with the presence of their elevated levels in patient’s body. Chronic phase markers have vast application in disease diagnosis, treatment, as well as study of disease condition and its stage which increases the demand in chronic phase markers market. These markers are majorly intended for detection of chronic diseases including tumors, rheumatoid inflammatory disease, thyroid cancer, chronic cardiac disorders and others. In a chronic phase, patients commonly have less than 10 percent blast cells present in the blood stream or bone marrow samples obtained from the affected individuals. Chronic phase markers are capable of extreme performance and do not allow confusion between acute and chronic phase detection. Many of these biomarkers work well as both acute and chronic phase markers and thus contribute majorly to the revenue generation in chronic phase markers market. These chronic phase markers are broadly used to diagnose cancerous conditions and thus generates large revenues in the chronic phase markers market owing to their increased demand in health-care centers. Chronic phase markers market on the basis of product type is classified into tumor markers, cardiac markers, inflammatory disease markers, thyroid markers and others.

However, the main customer base for chronic phase markers include hospitals and clinics, research and academic institutions, and diagnostic labs and centers. On the other hand, chronic phase markers market is gaining profit due to rising incidence of chronic diseases across the globe. Chronic myelogenous leukemia is one of the deadly chronic phase disease which registers 8,950 new cases in United States in 2017. Recently, new prognostic markers have been developed that enables improved diagnostics to detect chronic phase in less time. Such biological innovations tend to propel the growth of chronic phase markers market across the globe.

Chronic phase markers consist of various proteins and enzymes used for specific detection of human disease conditions and registers a significant revenue growth in the chronic phase markers market. These biomarkers are used for a variety of diseases including multiple types of cancer, diabetes, malaria, and others, and offers an affordable disease detection platform. This is further anticipated to drive the demand for chronic phase markers and thereby increasing revenue generation in chronic phase markers market.

Chronic Phase Markers: Market Dynamics

Growing awareness among individuals, availability of rapid and cost effective diagnostic chronic phase markers in the market, and a wide range of applications of chronic phase markers is expected to be the key factor driving the growth of chronic phase markers market. Technological advancement leading to development of novel prognostic markers due to developed healthcare infrastructure and rising healthcare expenditure are some other factors propelling the growth of chronic phase markers market. Also, rise in demand for chronic phase markers in the clinical usages, and research and academic institutions is further expected to drive the growth of chronic phase markers market. However, the lack of skilled microbiologists and manpower are some of the factors restraining the chronic phase markers market growth.

Chronic Phase Markers Market: Overview

Based on product type, tumor markers are most commonly used in the chronic phase markers market owing to the increased application of chronic phase markers in detection of chronic stage of the tumors and cost effective tests. Chronic phase markers found major applications in diagnosis of disease conditions progressing in chronic phase. Rising prevalence of cancer due to changing lifestyle is one of the major factor driving the demand of chronic phase markers in early diagnosis of cancer, thereby fueling the chronic phase markers market over the globe. However, the markers have significant applications in detection of wide range of chronic disease and accounts for a significant market share in global chronic phase markers market.

Chronic Phase Markers Market: Region-wise Outlook

On the basis of geography, global chronic phase markers market is segmented into seven key regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East & Africa. North America is projected to hold largest shares in the global chronic phase markers market primarily due to growing prevalence of multiple types of cancer among individuals, enhanced medical infrastructure and increased healthcare and R&D expenditure. North America is followed by Western Europe which is the second dominating region in global chronic phase markers market worldwide followed by Japan.

Request For Report sample @

Chronic Phase Markers Market: Key Players

Some of the key players present in global chronic phase markers market are Nordic BioSite, DiaSorin S.P.A., Roche Diagnostics Inc., Bristol-Myers Squibb Company, Hologic Inc., QIAGEN and others.

About Us

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

Contact Us

Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chronic Phase Markers Market Global Industry Analysis and Forecast Till 2027 here

News-ID: 827468 • Views: 115

More Releases from Future Market Insights

How Changing Dynamics of Cable Testing Market are Reflecting on Growth Strategie …
Global Cable Testing Market: Introduction The cost of the substitution of cables that are concealed is very high. Faults in the cable, bending, kinking, and crushing, are not always visible, which has created the requirement for cable testing. Thus, cable testing helps check the cable functionality, cable quality, and cable conformity. Several times, cable testing by visual inspection is an effective way of identifying the actual problem before it causes any
How Transformative Trends in Self-Organising Network Market are Molding Strategi …
Self-Organising Network: Introduction With accelerated advancements and increasing complexities in the radio network technologies, such as those utilised for the development of LTE and 5G networks, which are used for planning, management, configuration, healing and optimisation, are required to be automated to facilitate efficiency. At present, suppliers are offering self-organising networks that possess the ability to offer optimum performance. Self-organising networks are use cases that perform network governance, including network planning,
Mining Vehicle AC Kits Market: Exploring the Impact of Trends on Strategies of K …
Mining Vehicle AC Kits Market: Introduction Cabin space in mining equipment has become more sophisticated in the recent past. The installation of mining vehicle AC kits has evolved from an optional feature to a necessary feature. Mining equipment manufacturers have made advancements in technology related to efficiency, performance and cost of air conditioning systems in order to make them affordable and economical to enable low-budget and compact installations without compromising on
Key Factors to Fuel Growth of the Talent Acquisition & Staffing Technology and S …
With the growing importance of recruiting and retaining top talent effectively and efficiently, smart hiring processes are the need of the hour. It is about time organisations move beyond merely scrutinising resumes. Salaries and benefits are important factors, but adopting ways that would make candidates an important part of the hiring process will attract the best talent. Studies reveal that due to discrepancies in existing Applicant Tracking Systems (ATS), hiring

All 5 Releases

More Releases for Chronic

Narcotic Analgesics: Future of Chronic Pain Management
The development of tolerance for non-narcotic analgesics is the primarily reason behind the constantly increasing sales for narcotic analgesics. Attributing to the higher efficacy in pain management and quick onset of action, narcotic analgesics are largely used in palliative care services for treating patients suffering from neuropathic pain. Increasing focus on palliative care services in third world countries and readily available reimbursements are the key factors expected to boost the
Global Chronic Bacterial Prostatitis Market Research Report
Latest industry research report on: Global Chronic Bacterial Prostatitis Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts GlobalData's clinical trial report, Chronic Bacterial Prostatitis Global Clinical Trials Review, H1, 2017" provides an overview of Chronic Bacterial Prostatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Bacterial Prostatitis. Report includes an overview of trial numbers and their average
Boot chronic pain
For immediate release Due to our rushed lives and stressful environment, many people are suffering from chronic pain and fatigue. We feel permanently tired and are barely able to get through our normal day. One is able to change this status when following the guidelines the book "Tired of being Tired to the point of being Gatvol (Fed Up). Some people will need a team of medical practitioners to help them
Chronic Inflammatory Demyelinating Polyneuropathy (CIPD) Treatment Market
Chronic inflammatory demyelinating polyneuropathy (CIPD) is an autoimmune disorder of the peripheral nervous system characterized by the weakness and impaired sensory function in the arms and legs. This disorder is caused by damage to the myelin sheath, a fatty covering that wraps and protects nerve fibers. The nerves stimulate muscle contraction and transmit sensory information to the brain through electrical impulses. Myelin acts as an insulation and allows efficient flow
Chronic Idiopathic Constipation Market Research Report 2024
Constipation can be defined as reduced stool frequency or difficulty in passing stool. The frequency may be reduced to less than three times a week. Reduced or difficult stool passage includes hard lumpy stools, incomplete bowel movements, straining, incomplete evacuation, and need for manual removal of stool. Chronic idiopathic constipation (CIC) can be defined as more chronic or severe continuation of these above symptoms. Many times the cause of constipation
Targeting chronic pain
With the support of the Austrian Science Fund FWF, the neurophysiologist Ruth Drdla-Schutting is investigating the role astrocytes play in the genesis of chronic pain. With the help of innovative gene technology (DREADDs), scientists are tailoring treatment specifically to these cells that are the most numerous found in the central nervous system. Pain is an important protection system of the human body. But when it becomes chronic, as it frequently